Insider Transactions in Q1 2020 at Pfizer Inc (PFE)
Insider Transaction List (Q1 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2020
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,819
-5.22%
|
$809,846
$34.93 P/Share
|
|
Feb 28
2020
|
Albert Bourla Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,135
+12.46%
|
$894,645
$27.37 P/Share
|
|
Feb 28
2020
|
Loretta V Cangialosi Sr. Vice President, Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
18,669
-6.8%
|
$634,746
$34.93 P/Share
|
|
Feb 28
2020
|
Loretta V Cangialosi Sr. Vice President, Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
27,422
+16.31%
|
$740,394
$27.37 P/Share
|
|
Feb 28
2020
|
Frank A Damelio Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
130,834
-12.41%
|
$4,448,356
$34.93 P/Share
|
|
Feb 28
2020
|
Frank A Damelio Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
173,675
+23.8%
|
$4,689,225
$27.37 P/Share
|
|
Feb 28
2020
|
Mikael Dolsten President R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
39,446
-12.81%
|
$1,301,718
$33.42 P/Share
|
|
Feb 28
2020
|
Michael Goettler Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
16,224
-16.31%
|
$551,616
$34.93 P/Share
|
|
Feb 28
2020
|
Michael Goettler Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
22,852
+30.11%
|
$617,004
$27.37 P/Share
|
|
Feb 28
2020
|
Rady A Johnson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,891
-6.34%
|
$370,294
$34.93 P/Share
|
|
Feb 28
2020
|
Rady A Johnson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,996
+15.39%
|
$431,892
$27.37 P/Share
|
|
Feb 28
2020
|
Douglas M Lankler Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
29,266
-8.81%
|
$995,044
$34.93 P/Share
|
|
Feb 28
2020
|
Douglas M Lankler Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
38,848
+18.38%
|
$1,048,896
$27.37 P/Share
|
|
Feb 28
2020
|
Alexander R Mackenzie Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
29,357
-10.99%
|
$998,138
$34.93 P/Share
|
|
Feb 28
2020
|
Alexander R Mackenzie Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
37,934
+21.29%
|
$1,024,218
$27.37 P/Share
|
|
Feb 28
2020
|
Dawn Rogers Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
12,222
-22.05%
|
$415,548
$34.93 P/Share
|
|
Feb 28
2020
|
Dawn Rogers Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
17,824
+37.24%
|
$481,248
$27.37 P/Share
|
|
Feb 28
2020
|
Sally Susman Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
70,738
-17.15%
|
$2,405,092
$34.93 P/Share
|
|
Feb 28
2020
|
Sally Susman Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
91,408
+29.12%
|
$2,468,016
$27.37 P/Share
|
|
Feb 28
2020
|
John D Young Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
75,745
-7.76%
|
$2,575,330
$34.93 P/Share
|
|
Feb 28
2020
|
John D Young Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
100,548
+16.62%
|
$2,714,796
$27.37 P/Share
|
|
Feb 26
2020
|
Loretta V Cangialosi Sr. Vice President, Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
21,671
-5.47%
|
$758,485
$35.41 P/Share
|
|
Feb 26
2020
|
Loretta V Cangialosi Sr. Vice President, Controller |
BUY
Grant, award, or other acquisition
|
Direct |
3,797
+2.74%
|
-
|
|
Feb 26
2020
|
Loretta V Cangialosi Sr. Vice President, Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
24,155
+15.55%
|
$821,270
$34.59 P/Share
|
|
Feb 26
2020
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
74,726
-13.94%
|
$2,615,410
$35.76 P/Share
|
|
Feb 26
2020
|
Albert Bourla Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
88,567
+24.4%
|
$3,011,278
$34.59 P/Share
|
|
Feb 26
2020
|
Mikael Dolsten President R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
37,792
-5.62%
|
$1,284,928
$34.72 P/Share
|
|
Feb 26
2020
|
Mikael Dolsten President R&D |
BUY
Grant, award, or other acquisition
|
Direct |
45,566
+11.64%
|
-
|
|
Feb 26
2020
|
Frank A Damelio Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
145,477
-9.71%
|
$5,091,695
$35.41 P/Share
|
|
Feb 26
2020
|
Frank A Damelio Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
45,566
+7.95%
|
-
|
|
Feb 26
2020
|
Frank A Damelio Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
144,928
+23.11%
|
$4,927,552
$34.59 P/Share
|
|
Feb 26
2020
|
Michael Goettler Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
18,537
-13.45%
|
$648,795
$35.41 P/Share
|
|
Feb 26
2020
|
Michael Goettler Group President |
BUY
Grant, award, or other acquisition
|
Direct |
3,164
+6.1%
|
-
|
|
Feb 26
2020
|
Michael Goettler Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,129
+30.64%
|
$684,386
$34.59 P/Share
|
|
Feb 26
2020
|
Angela Hwang President, Global Biopharma |
SELL
Payment of exercise price or tax liability
|
Direct |
12,229
-19.47%
|
$428,015
$35.76 P/Share
|
|
Feb 26
2020
|
Angela Hwang President, Global Biopharma |
BUY
Exercise of conversion of derivative security
|
Direct |
14,493
+30.86%
|
$492,762
$34.59 P/Share
|
|
Feb 26
2020
|
Rady A Johnson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
31,757
-10.76%
|
$1,111,495
$35.41 P/Share
|
|
Feb 26
2020
|
Rady A Johnson Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
10,506
+9.2%
|
-
|
|
Feb 26
2020
|
Rady A Johnson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
33,414
+26.39%
|
$1,136,076
$34.59 P/Share
|
|
Feb 26
2020
|
Douglas M Lankler Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
90,417
-14.66%
|
$3,164,595
$35.41 P/Share
|
|
Feb 26
2020
|
Douglas M Lankler Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
34,175
+13.23%
|
-
|
|
Feb 26
2020
|
Douglas M Lankler Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
88,567
+31.8%
|
$3,011,278
$34.59 P/Share
|
|
Feb 26
2020
|
Dawn Rogers Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
12,774
-26.77%
|
$447,090
$35.76 P/Share
|
|
Feb 26
2020
|
Dawn Rogers Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,097
+37.66%
|
$513,298
$34.59 P/Share
|
|
Feb 26
2020
|
Sally Susman Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
72,253
-12.73%
|
$2,528,855
$35.41 P/Share
|
|
Feb 26
2020
|
Sally Susman Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
22,783
+10.08%
|
-
|
|
Feb 26
2020
|
Sally Susman Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
72,464
+28.64%
|
$2,463,776
$34.59 P/Share
|
|
Feb 26
2020
|
John D Young Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
145,425
-9.31%
|
$5,089,875
$35.41 P/Share
|
|
Feb 26
2020
|
John D Young Group President |
BUY
Grant, award, or other acquisition
|
Direct |
45,566
+7.66%
|
-
|
|
Feb 26
2020
|
John D Young Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
144,928
+22.34%
|
$4,927,552
$34.59 P/Share
|